Stay updated on Bumetanide Oral Liquid in ASD Children Clinical Trial
Sign up to get notified when there's something new on the Bumetanide Oral Liquid in ASD Children Clinical Trial page.

Latest updates to the Bumetanide Oral Liquid in ASD Children Clinical Trial page
- CheckyesterdayChange DetectedRevision number on the page updated from v3.6.5 to v3.6.6, indicating a software update to the site. There is no indication of changes to study content or data in this update.SummaryDifference0.0%

- Check8 days agoChange DetectedA new NIH funding reference (2017) was added to the study's identifiers, indicating funding information associated with the trial.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a software version change on the page. The underlying study information remains unchanged and this is a technical UI update.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a software update to the site. This update is behind the scenes and does not modify the displayed study details.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.0. This indicates a newer page version in the site's versioning system and does not convey changes to the study content.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page's help and navigation sections were updated with new items such as How to Read a Study Record, Common Questions, and How to Join a Study, and the Intervention/Treatment heading and a revision note were adjusted. These are minor UI refinements that clarify how to navigate and interpret the study record.SummaryDifference0.4%

Stay in the know with updates to Bumetanide Oral Liquid in ASD Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bumetanide Oral Liquid in ASD Children Clinical Trial page.